Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics

No Featured Image set

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics

04-12-2022

L.J.Schipper, K.G.Samsom, P.Snaebjornsson, T.Battaglia, L.J.W.Bosch, F.Lalezari, P.Priestley, C.Shale, A.J.van den Broek, N.Jacobs, P.Roepman, J.J.M.van der Hoeven, N.Steeghs, M.A.Vollebergh, S.Marchetti, E.Cuppen, …

No Featured Image set

Signatures 1 and 17 show increased propensity to create mutational hotspots in the human genome

22-09-2022

Claudia Arnedo-Pac, Ferran Muiños, Abel Gonzalez-Perez & Nuria Lopez-Bigas BioRxiv, September 19 2022, doi: https://doi.org/10.1101/2022.09.14.507952

No Featured Image set

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

11-08-2022

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M. Kas, Frank Rolfs, Catrin Lutz, Jessica K. Lee, Sjoerd Klarenbeek, Ian M. …

No Featured Image set

Genetic immune escape landscape in primary and metastatic cancer

04-08-2022

Francisco Martínez-Jiménez, Peter Priestley, Charles Shale, Jonathan Baber, Erik Rozemuller, Edwin Cuppen bioRxiv February 27, 2022 DOI: https://doi.org/10.1101/2022.02.23.481444

No Featured Image set

Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer

04-08-2022

Pauline A J Mendelaar, Debbie Robbrecht, Maud Rijnders, Ronald de Wit, Vanja de Weerd, Teoman Deger, Hans M Westgeest, Maureen …

No Featured Image set

Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma

04-08-2022

J. Alberto Nakauma-Gonzáleza, Maud Rijnders, Job van Riet, Michiel S.van der Heijden, Jens Voortman, EdwinCuppen, Niven Mehra, Sandra van Wilpe, …

No Featured Image set

Genomics – Guided Treatment of Rare Cancer Patients in DRUP

04-08-2022

L.R. Hoes, J.M. van Berge Henegouwen, H. van der Wijngaart, L.J. Zeverijn, D.L. van der Velden, J. van de Haar, …

No Featured Image set

Clinical impact of prospective whole genome sequencing in sarcoma patients

04-08-2022

L.J. Schipper, K. Monkhorst, K.G. Samsom, L.J.W. Bosch, P. Snaebjornsson, H. van Boven, P. Roepman, L.E. van der Kolk, W.J. …

No Featured Image set

T Cell-to-Stroma Enrichment (TSE) score: a gene expression metric that predicts response to immune checkpoint inhibitors in patients with urothelial cancer

04-08-2022

Maud Rijnders, J. Alberto Nakauma-González, Debbie G.J. Robbrecht, Alberto Gil-Jimenez, Maureen J.B. Aarts, Joost L. Boormans, Paul Hamberg, Michiel S. …

No Featured Image set

Personalized selection of experimental treatment in patients with advanced solid cancer is feasible using Whole Genome Sequencing

04-08-2022

M.A. Pruis, F.H. Groenendijk, K.S. Badloe, A. van Puffelen, D. Robbrecht, W.N.M. Dinjens, S. Sleijfer, A.C. Dingemans, J.H. von der …

No Featured Image set

Genomic and transcriptomic landscape of advanced renal cell cancer to individualize treatment strategy

04-08-2022

K. de Joode, W.S. van de Geer, G.J.L.H. van Leenders, P. Hamberg, H.M. Westgeest, A. Beeker, S.F. Oosting, J.M. van …

No Featured Image set

Substitution mutational signatures in whole-genome–sequenced cancers in the UK population

04-08-2022

Andrea Degasperi, Xueqing Zou, Tauanne Dias Amarante, Andrea Martinez-Martinez, Gene Ching Chiek Koh, João M. L. Dias, Laura Heskin, Lucia …

Terug naar het laatste nieuws

Wilt u op de hoogte blijven van nieuwe ontwikkelingen?

Abonneer u op onze nieuwsbrieven

Meer weten over de complete DNA-test?

Ga naar OncoAct.nl